A new injection portal for brachially inserted central venous catheter. A multicenter study

Hans Starkhammar, Mats Bengtsson, Thomas B. Gain, William Galen, Leif HÅKansson, John Hirsch, Brian W. Loggie, Earl S. Schuman, J. Michael Sterchi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Totally implantable portal systems are widely used for long-term central venous access. A new venous portal system inserted via the brachial veins (P.A.S. Port system, Pharmacia Deltec Inc, U.S.A.) was studied in five centres. From January 1988 through May 1989 61 systems were implanted. Fifty-two patients had malignant diseases. Nine cases had non-malignant disorders. The portals were implanted subcutaneously in the fore-arm and catheterization was done percutaneously (46) or by cutdown-technique (15) under local anesthesia. Catheter tip position was controlled by fluoroscopy or x-ray. The basilic vein (49) and the cephalic vein (12) were used. The total follow-up time for all systems was 323 months. Forty-five systems were still in use at the end of the observation period, six were explanted electively at the end of infusion therapy and six systems were still functioning at the time of the patient's death (at a maximum of 14 months after implantation). Temporary arm-phlebitis was noticed on the first postoperative week in five patients. Two P.A.S. Port systems were explanted due to infection and one because of skin rupture at the wound. One intact system was removed as it was thought to be leaking because of needle displacement. The P.A.S. Port system is easy and safe to implant with a high success rate and a low complication rate. It is well accepted by patients and nurses. The device should be advantageous in patients unsuitable for standard venous portal systems and offers an excellent alternative system for venous access.

Original languageEnglish
Pages (from-to)281-285
Number of pages5
JournalMedical Oncology and Tumor Pharmacotherapy
Volume7
Issue number4
DOIs
StatePublished - Dec 1990
Externally publishedYes

Fingerprint

Central Venous Catheters
Multicenter Studies
Portal System
Injections
Veins
Phlebitis
Fluoroscopy
Local Anesthesia
Catheterization
Needles
Rupture
Arm
Catheters
Nurses
Head
Observation
X-Rays
Equipment and Supplies
Skin
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)
  • Oncology

Cite this

Starkhammar, H., Bengtsson, M., Gain, T. B., Galen, W., HÅKansson, L., Hirsch, J., ... Sterchi, J. M. (1990). A new injection portal for brachially inserted central venous catheter. A multicenter study. Medical Oncology and Tumor Pharmacotherapy, 7(4), 281-285. https://doi.org/10.1007/BF02987107

A new injection portal for brachially inserted central venous catheter. A multicenter study. / Starkhammar, Hans; Bengtsson, Mats; Gain, Thomas B.; Galen, William; HÅKansson, Leif; Hirsch, John; Loggie, Brian W.; Schuman, Earl S.; Sterchi, J. Michael.

In: Medical Oncology and Tumor Pharmacotherapy, Vol. 7, No. 4, 12.1990, p. 281-285.

Research output: Contribution to journalArticle

Starkhammar, H, Bengtsson, M, Gain, TB, Galen, W, HÅKansson, L, Hirsch, J, Loggie, BW, Schuman, ES & Sterchi, JM 1990, 'A new injection portal for brachially inserted central venous catheter. A multicenter study', Medical Oncology and Tumor Pharmacotherapy, vol. 7, no. 4, pp. 281-285. https://doi.org/10.1007/BF02987107
Starkhammar, Hans ; Bengtsson, Mats ; Gain, Thomas B. ; Galen, William ; HÅKansson, Leif ; Hirsch, John ; Loggie, Brian W. ; Schuman, Earl S. ; Sterchi, J. Michael. / A new injection portal for brachially inserted central venous catheter. A multicenter study. In: Medical Oncology and Tumor Pharmacotherapy. 1990 ; Vol. 7, No. 4. pp. 281-285.
@article{22e7aa836ed24bf28f95948ee41c82a2,
title = "A new injection portal for brachially inserted central venous catheter. A multicenter study",
abstract = "Totally implantable portal systems are widely used for long-term central venous access. A new venous portal system inserted via the brachial veins (P.A.S. Port™ system, Pharmacia Deltec Inc, U.S.A.) was studied in five centres. From January 1988 through May 1989 61 systems were implanted. Fifty-two patients had malignant diseases. Nine cases had non-malignant disorders. The portals were implanted subcutaneously in the fore-arm and catheterization was done percutaneously (46) or by cutdown-technique (15) under local anesthesia. Catheter tip position was controlled by fluoroscopy or x-ray. The basilic vein (49) and the cephalic vein (12) were used. The total follow-up time for all systems was 323 months. Forty-five systems were still in use at the end of the observation period, six were explanted electively at the end of infusion therapy and six systems were still functioning at the time of the patient's death (at a maximum of 14 months after implantation). Temporary arm-phlebitis was noticed on the first postoperative week in five patients. Two P.A.S. Port™ systems were explanted due to infection and one because of skin rupture at the wound. One intact system was removed as it was thought to be leaking because of needle displacement. The P.A.S. Port™ system is easy and safe to implant with a high success rate and a low complication rate. It is well accepted by patients and nurses. The device should be advantageous in patients unsuitable for standard venous portal systems and offers an excellent alternative system for venous access.",
author = "Hans Starkhammar and Mats Bengtsson and Gain, {Thomas B.} and William Galen and Leif H{\AA}Kansson and John Hirsch and Loggie, {Brian W.} and Schuman, {Earl S.} and Sterchi, {J. Michael}",
year = "1990",
month = "12",
doi = "10.1007/BF02987107",
language = "English",
volume = "7",
pages = "281--285",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "4",

}

TY - JOUR

T1 - A new injection portal for brachially inserted central venous catheter. A multicenter study

AU - Starkhammar, Hans

AU - Bengtsson, Mats

AU - Gain, Thomas B.

AU - Galen, William

AU - HÅKansson, Leif

AU - Hirsch, John

AU - Loggie, Brian W.

AU - Schuman, Earl S.

AU - Sterchi, J. Michael

PY - 1990/12

Y1 - 1990/12

N2 - Totally implantable portal systems are widely used for long-term central venous access. A new venous portal system inserted via the brachial veins (P.A.S. Port™ system, Pharmacia Deltec Inc, U.S.A.) was studied in five centres. From January 1988 through May 1989 61 systems were implanted. Fifty-two patients had malignant diseases. Nine cases had non-malignant disorders. The portals were implanted subcutaneously in the fore-arm and catheterization was done percutaneously (46) or by cutdown-technique (15) under local anesthesia. Catheter tip position was controlled by fluoroscopy or x-ray. The basilic vein (49) and the cephalic vein (12) were used. The total follow-up time for all systems was 323 months. Forty-five systems were still in use at the end of the observation period, six were explanted electively at the end of infusion therapy and six systems were still functioning at the time of the patient's death (at a maximum of 14 months after implantation). Temporary arm-phlebitis was noticed on the first postoperative week in five patients. Two P.A.S. Port™ systems were explanted due to infection and one because of skin rupture at the wound. One intact system was removed as it was thought to be leaking because of needle displacement. The P.A.S. Port™ system is easy and safe to implant with a high success rate and a low complication rate. It is well accepted by patients and nurses. The device should be advantageous in patients unsuitable for standard venous portal systems and offers an excellent alternative system for venous access.

AB - Totally implantable portal systems are widely used for long-term central venous access. A new venous portal system inserted via the brachial veins (P.A.S. Port™ system, Pharmacia Deltec Inc, U.S.A.) was studied in five centres. From January 1988 through May 1989 61 systems were implanted. Fifty-two patients had malignant diseases. Nine cases had non-malignant disorders. The portals were implanted subcutaneously in the fore-arm and catheterization was done percutaneously (46) or by cutdown-technique (15) under local anesthesia. Catheter tip position was controlled by fluoroscopy or x-ray. The basilic vein (49) and the cephalic vein (12) were used. The total follow-up time for all systems was 323 months. Forty-five systems were still in use at the end of the observation period, six were explanted electively at the end of infusion therapy and six systems were still functioning at the time of the patient's death (at a maximum of 14 months after implantation). Temporary arm-phlebitis was noticed on the first postoperative week in five patients. Two P.A.S. Port™ systems were explanted due to infection and one because of skin rupture at the wound. One intact system was removed as it was thought to be leaking because of needle displacement. The P.A.S. Port™ system is easy and safe to implant with a high success rate and a low complication rate. It is well accepted by patients and nurses. The device should be advantageous in patients unsuitable for standard venous portal systems and offers an excellent alternative system for venous access.

UR - http://www.scopus.com/inward/record.url?scp=0025018373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025018373&partnerID=8YFLogxK

U2 - 10.1007/BF02987107

DO - 10.1007/BF02987107

M3 - Article

VL - 7

SP - 281

EP - 285

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 4

ER -